Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_assertion type Assertion NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_head.
- NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_assertion description "[MDR1 RNA levels were also increased in some cancers at relapse after chemotherapy, including ALL, ANLL, breast cancer, neuroblastoma, pheochromocytoma, and nodular, poorly differentiated lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_provenance.
- NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_assertion evidence source_evidence_literature NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_provenance.
- NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_assertion SIO_000772 2562856 NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_provenance.
- NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_assertion wasDerivedFrom befree-2016 NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_provenance.
- NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_assertion wasGeneratedBy ECO_0000203 NP1259031.RAVKUv-mVla3_jukl1VMp5kJQ5speDndCcqaPyaj1ZCwM130_provenance.